Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$48.5M | -$50.6M | -$70M | -$14.9M | -$14.2M | |
| Operating Income | -$467.8M | -$506M | -$490.8M | -$130.2M | -$115M | |
| EBITDA | -$419.3M | -$455.4M | -$420.9M | -$115.2M | -$100.8M | |
| Diluted EPS | -$0.98 | -$0.95 | -$0.81 | -$0.23 | -$0.18 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.6B | $1.2B | $1.1B | $853.7M | $1B | |
| Total Assets | $1.8B | $1.5B | $1.6B | $1.3B | $1.3B | |
| Current Liabilities | $36.3M | $45.4M | $46.3M | $60.7M | $48M | |
| Total Liabilities | $102.5M | $155.3M | $152.7M | $161.4M | $127.5M | |
| Total Equity | $1.7B | $1.4B | $1.4B | $1.1B | $1.2B | |
| Total Debt | $66.4M | $102.8M | $97.6M | $90.2M | $68.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$245.5M | -$273.4M | -$245M | -$92.8M | -$63.7M | |
| Cash From Investing | -$100.7M | $184M | -$126.2M | $66.1M | -$156.4M | |
| Cash From Financing | $299.5M | $13.3M | $419.4M | $5M | $270.6M | |
| Free Cash Flow | -$354M | -$338.1M | -$280.1M | -$110.7M | -$73.6M | |
QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.
In the current month, QS has received 0 Buy ratings 6 Hold ratings, and 4 Sell ratings. The QS average analyst price target in the past 3 months is $9.89.
According to analysts, the consensus estimate is that QuantumScape Corp. share price will drop to $9.89 per share over the next 12 months.
Analysts are divided on their view about QuantumScape Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that QuantumScape Corp. is a Buy and believe this share price will rise from its current level to $16.00.
The price target for QuantumScape Corp. over the next 1-year time period is forecast to be $9.89 according to 10 Wall Street analysts, 0 of them rate the stock a Buy, 4 rate the stock a Sell, and 6 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for QuantumScape Corp. is a Hold. 6 of 10 analysts rate the stock a Hold at this time.
You can purchase shares of QuantumScape Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase QuantumScape Corp. shares.
QuantumScape Corp. was last trading at $11.20 per share. This represents the most recent stock quote for QuantumScape Corp.. Yesterday, QuantumScape Corp. closed at $11.18 per share.
In order to purchase QuantumScape Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.